Preventive Health Care, 2003 Update: Screening for Lung Cancer: Updated Recommendations from the Canadian Task Force on Preventive Health Care
Prepared by V.A. Palda, MD, MSc, H.G.C. Van Spall, MD, BSc, with the Canadian Task Force on Preventive Health Care
These recommendations were finalized by the Task Force in June 2003.
![]()
Miettinen OS. Screening for lung cancer: can it be cost-effective? CMAJ. 2000;162(10):1431-6.
Morrison BJ. Interventions other than smoking cessation to prevent lung cancer. In: Canadian Task Force on the Periodic Health Examination. The Canadian guide to clinical preventive health care. Ottawa: Canada Communications Group; 1994. p. 780-6.
National Cancer Institute of Canada. Canadian Cancer Statistics 2002. Canada: Canadian Cancer Society, National Cancer Institute of Canada, Statistics Canada, Provincial/Territorial Cancer Registries, Health Canada; 2002. Available from: URL: http://www.cancer.ca/vgn/images/portal/cit_776/437843niw_2002stats-en.pdf
Gloeckler Ries LA. Influence of extent of disease, histology and demographic factors on lung cancer survival in the SEER population-based data. Seminars in Surgical Oncology 1994;10:21-30
Dobson R. Screening trial for lung cancer planned for UK. BMJ. 2000;320(7230):270.
Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, Teutsch SM, Atkins D. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 Suppl):21-35.
Manser RL, Irving LB, Stone C, Byrnes G, Abramson M, Campbell D. Screening for lung cancer (Cochrane Review). In: The Cochrane Library, Issue 4, 2002. Oxford: Update Software.
Kubik AK, Parkin DM, Zatloukal P. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer. 2000;89(11 Suppl):2363-8.
Marcus PM, Bergstralh EJ, Fagerstrom RM, Williams DE, Fontana R, Taylor WF, Prorok PC. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000;92(16):1308-16.
Nishii K, Ueoka H, Kiura K, Kodani T, Tabata M, Shibayama T, Gemba K, Kitajima T, Hiraki A, Kawaraya M, Nakayama T, Harada M. A case-control study of lung cancer screening in Okayama Prefecture, Japan. Lung Cancer. 2001;34(3):325-32.
Okamoto N, Suzuki T, Hasegawa H, Gotoh T, Hagiwara S, Sekimoto M, Kaneko M. Evaluation of a clinic-based screening program for lung cancer with a case-control design in Kanagawa, Japan. Lung Cancer. 1999;25(2):77-85.
Sagawa M, Tsubono Y, Saito Y, Sato M, Tsuji I, Takahashi S, Usuda K, Tanita T, Kondo T, Fujimura S. A case-control study for evaluating the efficacy of mass screening program for lung cancer in Miyagi Prefecture, Japan. Cancer. 2001;92(3):588-94.
Sobue T. A case-control study for evaluating lung cancer screening in Japan. Cancer. 2000;89(11 Suppl):2392-6.
Tsukada H, Kurita Y, Yokoyama A, Wakai S, Nakayama T, Sagawa M, Misawa H. An evaluation of screening for lung cancer in Niigata Prefecture, Japan: a population-based case-control study. Br J Cancer. 2001;85(9):1326-31.
Sone S, Takashima S, Li F, Yang Z, Honda T, Maruyama Y, Hasegawa M, Yamanda T, Kubo K, Hanamura K, Asakura K. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351(9111):1242-5.
Sone S, Li F, Yang ZG, Honda T, Maruyama Y, Takashima S, Hasegawa M, Kawakami S, Kubo K, Haniuda M, Yamanda T. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer. 2001;84(1):25-32.
Diederich S, Wormanns D, Lenzen H, Semik M, Thomas M, Peters PE. Screening for asymptomatic early bronchogenic carcinoma with low dose CT of the chest. Cancer. 2000;89(11 Suppl):2483-4.
Tiitola M, Kivisaari L, Huuskonen MS, Mattson K, Koskinen H, Lehtola H, Zitting A, Vehmas T. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 2002;35:17-22.
Swensen S, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Aughenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC, Pairolero PC. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 2002;165:508-513.
Sobue T, Moriyama N, Kaneko M, Kusumoto M, Kobayashi T, Tsuchiya R, Kakinuma R, Ohmatsu H, Nagai K, Nishiyama H, Matsui E. Eguchi K. Screening for lung cancer with low-dose helical computed tomography: Anti-Lung Cancer Association project. J Clin Oncol 2002;20(4):911-920.
Nawa T, Nakagawa T, Kusano S, Kawasaki Y, Sugawara Y, Nakata H. Lung cancer screening using low-dose spiral CT: Results of baseline and 1-year follow-up studies. Chest 2002;122(1):15-20.
Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, Heindel W. Screening for early lung cancer with low-dose spiral CT: Prevalence in 817 asymptomatic smokers. Radiology 2002;222(3):773-781.
US Preventive Services Task Force. Screening for lung cancer. In: Guide to Clinical Preventive Services: Second Edition (pp. 135-139). Alexandria, Virginia: International Medical Publishing. 1996.
Bach PB, Kelley MJ, Tate RC, McCrory DC. Screening for lung cancer: A review of the current literature. Chest 123: 72S-82S.
Bach PB, Niewoehner DE, Black WC; American College of Chest Physicians. Screening for lung cancer: The guidelines. Chest 123: 83S-88S.
Smith RA, Cokkinides V, von Eschenbach AC, Levin B, Cohen C, Runowicz CD, Sener S, Saslow D, Eyre HJ. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2002 Jan-Feb;52(1):8-22.
![]()
Link to Summary Table of Recommendations of this review
Reprinted in modified format by the Canadian
Task Force on Preventive Health Care![]()
Original Copyright
© 2000 Canadian Medical Association.
For any technical issues please contact: webmaster@ctfphc.org
Last modified:
September 13, 2004